Understanding the purpose and objective of stability studies at each product development phase is critical in designing and executing appropriate stability studies for pharmaceutical development.
Dr. Mike Radomsky, President and co-founder of CMC Pharmaceuticals, has laid out the importance of conducting stability studies throughout the various stages of drug product development. Download the free white paper below to better understand the objective of these studies and when and why they are performed at different stages of drug product development. The team at CMC Pharma, along with Dr. Radomsky, are ready to help you navigate these critical studies and advance your program. CMC Pharma has current capacity to start work on your project right away–contact us today to schedule a call with a scientist.